EndoGastric Solutions closed a $45 million series I round to fuel commercialization efforts around its TIF 2.0 procedure.
What you should know:
1. Growth capital medical device investor Accelmed led the round.
2. Accelmed co-founder and managing partner Uri Geiger, PhD, will join EndoGastric Solutions' board.
3. EndoGastric Solutions previously closed a $30.5 million funding round in July 2018.
https://www.businesswire.com/news/home/20180710005599/en/EndoGastric-Solutions-Secures-30.5-Million-New-Financing
"With the closing of this round, we have established a strong financial foundation from which to leverage the significant growth opportunities ahead of us and achieve long-term commercial viability," said EndoGastric Solutions President and CEO Skip Baldino.
More articles on gastroenterology:
Now-defunct Laser Spine Institute under fire over insurance handling — 5 key details
Washington passes surprise-billing law
3 ways ASCs can improve cash flow